泰拉生物科学首席执行官托德·哈里斯10月15日出售10 035股,10月17日出售15 394股。 Tyra Biosciences CEO Todd Harris sold 10,035 shares on Oct 15 and 15,394 shares on Oct 17.

Tyra生物科学首席执行官Todd Harris于10月15日出售10 035股股票, Tyra Biosciences CEO Todd Harris sold 10,035 shares on October 15 for approximately $243,950, following previous sales in recent months. 10月17日,他又出售了15 394股,价值约397 935美元,留下1 418 647股。 On October 17, he sold an additional 15,394 shares for about $397,935, leaving him with 1,418,647 shares. 该公司侧重于FGFR生物学的精密药物,最近报告EPS为(0.32美元),超过了分析师的预期。 The company, focused on precision medicines for FGFR biology, recently reported an EPS of ($0.32), exceeding analyst expectations. 在贸易期间,TYRA股份上升到25.98美元。 TYRA shares rose to $25.98 during trading.